Pharmaceutical Supply – Guaifenesin Extended-Release Medication

The contract entails the supply and delivery of five bottles of Guaifenesin Extended-Release medication, identified by NSN 6505015393176, to a U.S. Navy vessel operating overseas. All packaging and labeling must conform to military and pharmaceutical standards, ensuring the product is properly prepared for use in a deployed environment. Delivery is required under FOB destination terms, meaning the vendor assumes full responsibility for transportation costs and risks until the medication reaches its final destination on the vessel. The performance deadline is strictly set for July 14, 2026, with no flexibility implied in the timeline. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, and falls under the NAICS code 325412 for pharmaceutical and botanical product manufacturing. The delivery location is not explicitly detailed beyond being overseas aboard a Navy vessel, and the contract is not subject to any specific set-aside provisions.